Summary - PACB - NASDAQ - Weiss Ratings

E

Pacific Biosciences of California, Inc. PACB

$1.06 -$0.04-3.64% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$1.06 - $2.72

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Biotechnology Health Care Life Sciences Tools and Services Pharmaceutical

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

1 Russell 2000 Stock with Exciting Potential and 2 to Approach with Caution

5/14/2025 - StockStory Articles

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

5/12/2025 - Globe Newswire

PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates

5/9/2025 - Zacks Investment Research

Q1 2025 Pacific Biosciences of California Inc Earnings Call Transcript

5/9/2025 - GuruFocus

Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say

5/9/2025 - Zacks Investment Research

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

5/8/2025 - SeekingAlpha

Pacific Biosciences of California, Inc. (PACB) Q1 2025 Earnings Call Transcript

5/8/2025 - Seeking Alpha: Transcripts

Pacific Biosciences of California, Inc. 2025 Q1 - Results - Earnings Call Presentation

5/8/2025 - SeekingAlpha

PacBio (NASDAQ:PACB) Beats Expectations in Strong Q1

5/8/2025 - StockStory Articles

Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates

5/8/2025 - Zacks Investment Research

PacBio Announces First Quarter 2025 Financial Results

5/8/2025 - Globe Newswire

Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result

5/7/2025 - GuruFocus

PacBio (PACB) Q1 Earnings: What To Expect

5/7/2025 - StockStory Articles

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Price T Rowe Associates Inc. MD

5/6/2025 - Ticker Report

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

5/5/2025 - Globe Newswire

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Recommendation of "Moderate Buy" from Analysts

5/5/2025 - MarketBeat

Pacific Biosciences of California (PACB) Expected to Announce Earnings on Thursday

5/3/2025 - MarketBeat

Soros Fund Management LLC Increases Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

5/1/2025 - MarketBeat

Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know

4/29/2025 - Zacks Investment Research

Cathie Wood just went big on this Michael Burry stock

4/29/2025 - Finbold Stock News

PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

4/28/2025 - Globe Newswire

1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar

4/28/2025 - StockStory Articles

T. Rowe Price Investment Management Inc. Takes Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

4/28/2025 - Ticker Report

Commit To Buy Pacific Biosciences of California At $1, Earn 49.7% Annualized Using Options

4/25/2025 - Stock Options Channel

Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know

4/23/2025 - Zacks Investment Research

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Monday, May 12, 2025

Period Date

Monday, March 31, 2025

Next Filing

Week of Aug 4 and 8 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Apr 30, 2025 - $1.06

52-week High

Nov 07, 2024 - $2.72

Valuation

Market Cap

$345.10M - Small Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

650 521 8000

Address

1305 O’Brien Drive
Menlo Park, CA 94025

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable... more